Both in Biotechnology
Sana Biotechnology vs Cullinan Therapeutics
Over the past year SANA returned −47.6% and CGEM returned +76.2%; their daily moves had a correlation of 0.38.
SANA −47.6% CGEM +76.2%Growth of $1, one year, split-adjusted
| Metric | SANA | CGEM |
|---|---|---|
| Price | $2.33 | $13.64 |
| Market cap | $697.5M | $877.8M |
| Today | −3.32% | −3.26% |
| 1 month | −26.3% | −33.6% |
| 6 months | −32.3% | −8.8% |
| Year to date | −42.8% | +31.8% |
| 1 year | −46.4% | +74.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $160.5M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 68.7% | 72.5% |
| Short % of float | 21.0% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).